معرفی
Alan Morrison is an Adjunct Lecturer in Biological Sciences at Columbia University, specializing in biotechnology and pharmaceutical law. His career spans roles as a partner at prominent law firms (Cozen O’Connor, Cohen Pontani, Cooper & Dunham) and in-house counsel at Johnson & Johnson. He focuses on patent prosecution, legal opinions, and regulatory transactions for corporations, universities, and research institutes.
- Education: B.A. in Biochemistry (UC Berkeley), M.S. in Biological Chemistry (University of Michigan), M.Phil. in Biochemistry & Molecular Biophysics (Columbia), J.D. (Yeshiva University)
Research Interests center on intellectual property law in biotechnology, including gene patenting, recombinant antibody drugs, and small molecule synthesis. His work intersects patent law with scientific innovation, particularly in DNA microarrays, molecular diagnostics, and stem cell technologies.
Publications highlight trends in biotech legal frameworks, such as gene patenting (2010), DNA patents (2009), and biosimilars regulation (2007). His articles address controversies in pharmaceutical IP and therapeutic antibody industry challenges.
Advisory Roles: Co-chair Emeritus of the Bellevue/NYU Program for Survivors of Torture advisory board, and member of the Stem Cell Partnering Series and Columbia University Biotechnology Association boards.
